Agios Pharmaceuticals Appoints John Maraganore, Ph.D., to Board of Directors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, today announced the appointment of John Maraganore, Ph.D., to its Board of Directors. Dr. Maraganore is the CEO of Alnylam Pharmaceuticals and is the first independent director of Agios.